Vyleesi Approval Expands Treatment Options For Female Hypoactive Sexual Desire Disorder 82% of people regain the weight within a year of stopping GLP 1 medications. Your hunger rebounds harder, your metabolism has already adapted, and there's no standard plan to come off. The research Kaiser denies GLP 1s due to weight requirement Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women Tran 2017 Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Wiley Online Library